Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignanciesDidier Blaise, Anne-Marie Stoppa, Catherine Faucher et al.|Experimental Hematology|2010Cited by 39